Beta adrenergic inhibition of capsaicin-induced, NK 1 receptor-mediated nerve growth factor biosynthesis in rat skin

Pain

Volumn 112, Issue 1-2, 2004, Pages 76-82

  Amann, Rainer ^a   Schuligoi, Rufina ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Beta adrenergic inhibition; Nerve growth factor; Neurotrophin; Primary afferent neurons

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPSAICIN; CARRAGEENAN; INDOMETACIN; NERVE GROWTH FACTOR; NEUROKININ 1 RECEPTOR; NOLPITANTIUM; PROPRANOLOL; SUBSTANCE P; TERBUTALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; MALE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE; SKIN;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NERVE GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, NEUROKININ-1; SKIN;

EID: 5644289915     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2004.08.002     Document Type: Article

References (63)

1. L. Aloe, M.D. Simone, and F. Properzi Nerve growth factor: a neurotrophin with activity on cells of the immune system Microsc Res Tech 45 1999 285 291
2. R. Amann, and P. Holzer Capsaicin and analogs P.S. Spencer H.H. Schaumburg A.C. Ludolph Experimental and clinical neurotoxicology second ed 2000 Oxford University Press Oxford 284 288
3. R. Amann, and R. Schuligoi Inhibition of carrageenan-induced edema by indomethacin or sodium salicylate does not prevent the increase of nerve growth factor in the rat hind paw Neurosci Lett 278 2000 173 176
4. 1 receptor antagonist SR140333 produces long-lasting inhibition of neurogenic inflammation, but does not influence acute chemo- or thermonociception in rats Naunyn Schmiedebergs Arch Pharmacol 352 1995 201 205
5. R. Amann, T. Egger, and R. Schuligoi The tachykinin NK(1) receptor antagonist SR140333 prevents the increase of nerve growth factor in rat paw skin induced by substance P or neurogenic inflammation Neuroscience 100 2000 611 615
6. R. Amann, B.A. Peskar, and R. Schuligoi Effects of terbutaline on NGF formation in allergic inflammation of the rat Br J Pharmacol 133 2001 186 192
7. T. Andoh, and Y. Kuraishi Nitric oxide enhances substance P-induced itch-associated responses in mice Br J Pharmacol 138 2003 202 208
8. L. Andreeva, and H.P. Rang Effect of bradykinin and prostaglandins on the release of calcitonin gene-related peptide-like immunoreactivity from the rat spinal cord in vitro Br J Pharmacol 108 1993 185 190
9. P.J. Barnes Effect of beta-agonists on inflammatory cells J Allergy Clin Immunol 104 1999 S10 S17
10. A.I. Basbaum, and J.D. Levine The contribution of the nervous system to inflammation and inflammatory disease Can J Physiol Pharmacol 69 1991 647 651
11. G. Bennett, S. al-Rashed, J.R. Hoult, and S.D. Brain Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils Pain 77 1998 315 322
12. R. Bernabei, F. Landi, S. Bonini, G. Onder, A. Lambiase, R. Pola, and L. Aloe Effect of topical application of nerve-growth factor on pressure ulcers Lancet 354 1999 307
13. S.C. Bischoff, and C.A. Dahinden Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils Blood 79 1992 2662 2669
14. G.J. Burbach, K.H. Kim, A.S. Zivony, A. Kim, J. Aranda, S. Wright, S.M. Naik, S.W. Caughman, J.C. Ansel, and C.A. Armstrong The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor J Invest Dermatol 117 2001 1075 1082
15. M.C. Caroleo, N. Costa, L. Bracci-Laudiero, and L. Aloe Human monocyte/macrophages activate by exposure to LPS overexpress NGF and NGF receptors J Neuroimmunol 113 2001 193 201
16. H.M. Chang, L. Wang, X.P. Zhang, R.M. Kream, and E.T. Yeh Modulation of substance P release in primary sensory neurons by misoprostol and prostaglandins Am J Ther 3 1996 276 279
17. H. Chiao, and R.W. Caldwell The role of substance P in myocardial dysfunction during ischemia and reperfusion Naunyn Schmiedebergs Arch Pharmacol 353 1996 400 407
18. M.K. Church, and J. Hiroi Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol Br J Pharmacol 90 1987 421 429
19. P. Delay-Goyet, H. Satoh, and J.M. Lundberg Relative involvement of substance P and CGRP mechanisms in antidromic vasodilation in the rat skin Acta Physiol Scand 146 1992 537 538
20. E. Di Marco, P.C. Marchisio, S. Bondanza, A.T. Franzi, R. Cancedda, and M. De Luca Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes J Biol Chem 266 1991 21718 21722
21. J. Donnerer, R. Schuligoi, C. Stein, and R. Amann Upregulation, release and axonal transport of substance P and calcitonin gene-related peptide in adjuvant inflammation and regulatory function of nerve growth factor Regul Pept 46 1993 150 154
22. 1 receptors Eur J Pharmacol 209 1991 277 279
23. C. Emanueli, M.B. Salis, A. Pinna, G. Graiani, L. Manni, and P. Madeddu Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs Circulation 106 2002 2257 2262
24. 1 receptor antagonist Eur J Pharmacol 250 1993 403 413
25. P.A. Foster, S. Wicks, M. Foster, and S.D. Brain Cellular pathology changes in rat skin following intradermal injection of nerve growth factor: neutrophil-dependent and -independent events J Pathol 197 2002 245 255
26. A. Franco-Cereceda Calcitonin gene-related peptide and tachykinins in relation to local sensory control of cardiac contractility and coronary vascular tone Acta Physiol Scand Suppl 569 1988 1 63
27. H.O. Handwerker Influences of algogenic substances and prostaglandins on the discharges of unmyelinated cutaneous nerve fibers identified as nociceptors J.J. Bonica D. Albe-Fessard Advances in pain research and therapy vol. 1 1976 Raven Press New York 41 45
28. P. Holzer Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons Pharmacol Rev 43 1991 143 201
29. K. Horigome, J.C. Pryor, E.D. Bullock, and E.M. Johnson Jr. Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation J Biol Chem 268 1993 14881 14887
30. S.R. Hughes, and S.D. Brain A calcitonin gene-related peptide (CGRP) antagonist (CGRP8-37) inhibits microvascular responses induced by CGRP and capsaicin in skin Br J Pharmacol 104 1991 738 742
31. N. Jancso, A. Jancso-Gabor, and J. Szolcsanyi Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin Br J Pharmacol 31 1967 138 151
32. M. Johnson Effects of beta2-agonists on resident and infiltrating inflammatory cells J Allergy Clin Immunol 110 2002 S282 S290
33. G. Kallner, A. Gonon, and A. Franco-Cereceda Calcitonin gene-related peptide in myocardial ischaemia and reperfusion in the pig Cardiovasc Res 38 1998 493 499
34. N. Kanda, and S. Watanabe Substance P enhances the production of interferon-induced protein of 10 kDa by human keratinocytes in synergy with interferon-gamma J Invest Dermatol 119 2002 1290 1297
35. M.A. Kido, T. Yamaza, T. Goto, and T. Tanaka Immunocytochemical localization of substance P neurokinin-1 receptors in rat gingival tissue Cell Tissue Res 297 1999 213 222
36. W.C. Koff, A.V. Fann, M.A. Dunegan, and L.B. Lachman Catecholamine- induced suppression of interleukin-1 production Lymphokine Res 5 1986 239 247
37. A. Lambiase, P. Rama, S. Bonini, G. Caprioglio, and L. Aloe Topical treatment with nerve growth factor for corneal neurotrophic ulcers N Engl J Med 338 1998 1174 1180
38. F. Lembeck, G. Bernatzky, R. Gamse, and A. Saria Characterization of substance P-like immunoreactivity in submammalian species by high performance liquid chromatography Peptides 6 Suppl. 3 1985 231 236
39. A. Leon, A. Buriani, R. Dal Toso, M. Fabris, S. Romanello, L. Aloe, and R. Levi-Montalcini Mast cells synthesize, store, and release nerve growth factor Proc Natl Acad Sci USA 91 1994 3739 3743
40. J.D. Levine, S.J. Dardick, M.F. Roizen, C. Helms, and A.I. Basbaum Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis J Neurosci 6 1986 3423 3429
41. J.D. Levine, T.J. Coderre, C. Helms, and A.I. Basbaum Beta 2-adrenergic mechanisms in experimental arthritis Proc Natl Acad Sci USA 85 1988 4553 4556
42. G.R. Lewin, and L.M. Mendell Nerve growth factor and nociception Trends Neurosci 16 1993 353 359
43. R.M. Lindsay, and A.J. Harmar Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons Nature 337 1989 362 364
44. M. Lotz, J.H. Vaughan, and D.A. Carson Effect of neuropeptides on production of inflammatory cytokines by human monocytes Science 241 1988 1218 1221
45. H. Matsuda, H. Koyama, H. Sato, J. Sawada, A. Itakura, A. Tanaka, M. Matsumoto, K. Konno, H. Ushio, and K. Matsuda Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice J Exp Med 187 1998 297 306
46. Y.A. Mekori, and D.D. Metcalfe Mast cells in innate immunity Immunol Rev 173 2000 131 140
47. T. Okada, Y. Hirayama, S. Kishi, K. Miyayasu, J. Hiroi, and T. Fujii Functional neurokinin NK-1 receptor expression in rat peritoneal mast cells Inflamm Res 48 1999 274 279
48. N.E. Saade, C.A. Massaad, C.I. Ochoa-Chaar, S.J. Jabbur, B. Safieh-Garabedian, and S.F. Atweh Upregulation of proinflammatory cytokines and nerve growth factor by intraplantar injection of capsaicin in rats J Physiol 545 2002 241 253
49. D.W. Sah, M.H. Ossipo, and F. Porreca Neurotrophic factors as novel therapeutics for neuropathic pain Nat Rev Drug Discov 2 2003 460 472
50. A. Saria Substance P in sensory nerve fibres contributes to the development of oedema in the rat hind paw after thermal injury Br J Pharmacol 82 1984 217 222
51. K.U. Schallreuter, K.R. Lemke, M.R. Pittelkow, J.M. Wood, C. Korner, and R. Malik Catecholamines in human keratinocyte differentiation J Invest Dermatol 104 1995 953 957
52. A. Severn, N.T. Rapson, C.A. Hunter, and F.Y. Liew Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists J Immunol 148 1992 3441 3445
53. I.S. Song, N.W. Bunnett, J.E. Olerud, B. Harten, M. Steinhoff, J.R. Brown, K.J. Sung, C.A. Armstrong, and J.C. Ansel Substance P induction of murine keratinocyte PAM 212 interleukin 1 production is mediated by the neurokinin 2 receptor (NK-2R) Exp Dermatol 9 2000 42 52
54. V. Steinkraus, J.C. Mak, U. Pichlmeier, H. Mensing, J. Ring, and P.J. Barnes Autoradiographic mapping of beta-adrenoceptors in human skin Arch Dermatol Res 288 1996 549 553
55. R. Suzuki, T. Furuno, D.M. McKay, D. Wolvers, R. Teshima, M. Nakanishi, and J. Bienenstock Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P J Immunol 163 1999 2410 2415
56. H.K. Takahashi, T. Morichika, H. Iwagaki, T. Yoshino, R. Tamura, S. Saito, S. Mori, T. Akagi, N. Tanaka, and M. Nishibori Effect of beta 2-adrenergic receptor stimulation on interleukin-18-induced intercellular adhesion molecule-1 expression and cytokine production J Pharmacol Exp Ther 304 2003 634 642
57. P. Turrini, C. Gaetano, A. Antonelli, M.C. Capogrossi, and L. Aloe Nerve growth factor induces angiogenic activity in a mouse model of hindlimb ischemia Neurosci Lett 323 2002 109 112
58. M. Tuveri, S. Generini, M. Matucci-Cerinic, and L. Aloe NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis Lancet 356 2000 1739 1740
59. E.E. Ustinova, D. Bergren, and H.D. Schultz Neuropeptide depletion impairs postischemic recovery of the isolated rat heart: role of substance P Cardiovasc Res 30 1995 55 63
60. H.P. van der Kleij, D. Ma, F.A. Redegeld, A.D. Kraneveld, F.P. Nijkamp, and J. Bienenstock Functional expression of neurokinin 1 receptors on mast cells induced by IL-4 and stem cell factor J Immunol 171 2003 2074 2079
61. X.J. Xu, C.J. Dalsgaard, C.A. Maggi, and Z. Wiesenfeld-Hallin NK-1, but not NK-2, tachykinin receptors mediate plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw: demonstrated with the NK-1 antagonist CP-96,345 and the NK-2 antagonist Men 10207 Neurosci Lett 139 1992 249 252
62. N. Yonehara, T. Shibutani, and R. Inoki Contribution of substance P to heat-induced edema in rat paw J Pharmacol Exp Ther 242 1987 1071 1076
63. M. Zimmermann Ethical guidelines for investigations of experimental pain in conscious animals Pain 16 1983 109 110